Sartorius Stedim Biotech: Statement on Share Capital

On March 2, 2026, Sartorius Stedim Biotech SA disclosed details of its share capital structure and voting rights, in accordance with regulatory requirements. As of February 28, 2026, the company's share capital consisted of 97,330,405 shares. The total number of theoretical voting rights reached 164,793,754, including treasury shares. The net number of voting rights amounted to 164,751,543. This disclosure complies with Articles L 233-8-II of the French Commercial Code and 223-6 of the AMF General Regulation. Sartorius Stedim Biotech, based in Aubagne, France, continues to keep its shareholders informed of its share capital structure.